Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 140

1.

Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition.

Hemming ML, Lawlor MA, Andersen JL, Hagan T, Chipashvili O, Scott TG, Raut CP, Sicinska E, Armstrong SA, Demetri GD, Bradner JE.

Cancer Res. 2019 Jan 10. pii: canres.1888.2018. doi: 10.1158/0008-5472.CAN-18-1888. [Epub ahead of print]

PMID:
30630822
2.

Radiotherapy for retroperitoneal liposarcoma: A report from the Transatlantic Retroperitoneal Sarcoma Working Group.

Haas RLM, Bonvalot S, Miceli R, Strauss DC, Swallow CJ, Hohenberger P, van Coevorden F, Rutkowski P, Callegaro D, Hayes AJ, Honoré C, Fairweather M, Gladdy R, Jakob J, Szacht M, Fiore M, Chung PW, van Houdt WJ, Raut CP, Gronchi A.

Cancer. 2019 Jan 2. doi: 10.1002/cncr.31927. [Epub ahead of print]

PMID:
30602058
3.

Clinical characteristics and treatment outcomes in six cases of malignant tenosynovial giant cell tumor: initial experience of molecularly targeted therapy.

Nakayama R, Jagannathan JP, Ramaiya N, Ferrone ML, Raut CP, Ready JE, Hornick JL, Wagner AJ.

BMC Cancer. 2018 Dec 29;18(1):1296. doi: 10.1186/s12885-018-5188-6.

4.

Comparative evaluation of chlorhexidine and cinnamon extract used in dental unit waterlines to reduce bacterial load in aerosols during ultrasonic scaling.

Mamajiwala AS, Sethi KS, Raut CP, Karde PA, Khedkar SU.

Indian J Dent Res. 2018 Nov-Dec;29(6):749-754. doi: 10.4103/ijdr.IJDR_571_17.

5.

Gastrointestinal Stromal Tumors.

Hohenberger P, Montemurro M, Raut CP, Rutkowski P.

Visc Med. 2018 Oct;34(5):376-379. doi: 10.1159/000493934. Epub 2018 Oct 16. No abstract available.

6.

Tumor Biological Aspects of Epithelial versus Mesenchymal Tumors of the Gastrointestinal Tract.

Raut CP.

Visc Med. 2018 Oct;34(5):342-346. doi: 10.1159/000493474. Epub 2018 Oct 28. Review.

PMID:
30498700
7.

Gastrointestinal Stromal Tumors.

Hohenberger P, Raut CP, Rutkowski P.

Visc Med. 2018 Oct;34(5):332-333. doi: 10.1159/000494077. Epub 2018 Oct 16. No abstract available.

8.

Efficacy and Tolerability of 5-Year Adjuvant Imatinib Treatment for Patients With Resected Intermediate- or High-Risk Primary Gastrointestinal Stromal Tumor: The PERSIST-5 Clinical Trial.

Raut CP, Espat NJ, Maki RG, Araujo DM, Trent J, Williams TF, Purkayastha DD, DeMatteo RP.

JAMA Oncol. 2018 Dec 1;4(12):e184060. doi: 10.1001/jamaoncol.2018.4060. Epub 2018 Dec 13.

PMID:
30383140
9.

ASO Author Reflections: Rationale for Organ Resection for Retroperitoneal Sarcomas.

Fairweather M, Raut CP.

Ann Surg Oncol. 2018 Dec;25(Suppl 3):940-941. doi: 10.1245/s10434-018-6979-3. Epub 2018 Oct 30. No abstract available.

PMID:
30377921
10.

Cutaneous Breast Radiation-associated Angiosarcoma: Anterior Chest Wall Reconstruction Options Following Extra-radical Resection.

Mella JR, Ross KM, Li GZ, Pomahac B, Raut CP, Orgill DP.

Plast Reconstr Surg Glob Open. 2018 Sep 5;6(9):e1938. doi: 10.1097/GOX.0000000000001938. eCollection 2018 Sep.

11.

Local Cancer Recurrence: The Realities, Challenges, and Opportunities for New Therapies.

Mahvi DA, Liu R, Grinstaff MW, Colson YL, Raut CP.

CA Cancer J Clin. 2018 Nov;68(6):488-505. doi: 10.3322/caac.21498. Epub 2018 Oct 17. Review.

12.

A call to action: Why sarcoma surgery needs to be centralized.

Raut CP, Bonvalot S, Gronchi A.

Cancer. 2018 Dec 1;124(23):4452-4454. doi: 10.1002/cncr.31749. Epub 2018 Oct 14. No abstract available.

PMID:
30317538
13.

Effect of low-level laser therapy on wound healing and patients' response after scalpel gingivectomy: A randomized clinical split-mouth study.

Kohale BR, Agrawal AA, Raut CP.

J Indian Soc Periodontol. 2018 Sep-Oct;22(5):419-426. doi: 10.4103/jisp.jisp_239_18.

14.

Assessment of the Accuracy of Disease Coding Among Patients Diagnosed With Sarcoma.

Lyu HG, Stein LA, Saadat LV, Phicil SN, Haider A, Raut CP; Dana-Farber/Brigham and Women’s Cancer Center Sarcoma Surgery Group.

JAMA Oncol. 2018 Sep 1;4(9):1293-1295. doi: 10.1001/jamaoncol.2018.2979. No abstract available.

PMID:
30098150
15.

Indocyanine green-mediated photothermal therapy in treatment of chronic periodontitis: A clinico-microbiological study.

Raut CP, Sethi KS, Kohale BR, Mamajiwala A, Warang A.

J Indian Soc Periodontol. 2018 May-Jun;22(3):221-227. doi: 10.4103/jisp.jisp_128_18.

16.

Minimally Invasive Surgery for Retroperitoneal Sarcoma: Just Because We Can Does Not Mean We Should.

Gronchi A, Crago A, Raut CP.

Ann Surg Oncol. 2018 Aug;25(8):2129-2131. doi: 10.1245/s10434-018-6572-9. Epub 2018 Jun 14. No abstract available.

PMID:
29948424
17.

Gastrointestinal stromal tumor enhancers support a transcription factor network predictive of clinical outcome.

Hemming ML, Lawlor MA, Zeid R, Lesluyes T, Fletcher JA, Raut CP, Sicinska ET, Chibon F, Armstrong SA, Demetri GD, Bradner JE.

Proc Natl Acad Sci U S A. 2018 Jun 19;115(25):E5746-E5755. doi: 10.1073/pnas.1802079115. Epub 2018 Jun 4.

18.

Evaluation of diode laser and stannous fluoride in the treatment of root sensitivity after access flap surgery: Randomized controlled clinical trial.

Raut CP, Sethi KS, Kohale B, Mamajiwala A, Warang A.

J Indian Soc Periodontol. 2018 Mar-Apr;22(2):158-163. doi: 10.4103/jisp.jisp_2_18.

19.

Prediction of morbidity following cytoreductive surgery for metastatic gastrointestinal stromal tumour in patients on tyrosine kinase inhibitor therapy.

Fairweather M, Cavnar MJ, Li GZ, Bertagnolli MM, DeMatteo RP, Raut CP.

Br J Surg. 2018 May;105(6):743-750. doi: 10.1002/bjs.10774. Epub 2018 Mar 26.

PMID:
29579329
20.

Current principles of surgery for retroperitoneal sarcomas.

Fairweather M, Gonzalez RJ, Strauss D, Raut CP.

J Surg Oncol. 2018 Jan;117(1):33-41. doi: 10.1002/jso.24919. Epub 2018 Jan 8. Review.

PMID:
29315649
21.

The impact of lipomatous tumors on type 2 diabetes: are adipose-derived tumors metabolically active?

Fallahian F, Ardestani A, Pranckevicius E, Raut CP, Tavakkoli A, Sheu EG.

J Surg Res. 2018 Feb;222:48-54. doi: 10.1016/j.jss.2017.09.040. Epub 2017 Nov 1.

PMID:
29273375
22.

Amputation for Sarcoma: Revisiting a 19th Century Treatment in the 21st Century.

Erstad DJ, Raut CP.

Ann Surg Oncol. 2018 Feb;25(2):351-353. doi: 10.1245/s10434-017-6243-2. Epub 2017 Nov 27. No abstract available.

PMID:
29181684
23.

Amputation for Extremity Sarcoma: Contemporary Indications and Outcomes.

Erstad DJ, Ready J, Abraham J, Ferrone ML, Bertagnolli MM, Baldini EH, Raut CP.

Ann Surg Oncol. 2018 Feb;25(2):394-403. doi: 10.1245/s10434-017-6240-5. Epub 2017 Nov 22.

PMID:
29168103
24.

Surgical Management of Primary Retroperitoneal Sarcomas: Rationale for Selective Organ Resection.

Fairweather M, Wang J, Jo VY, Baldini EH, Bertagnolli MM, Raut CP.

Ann Surg Oncol. 2018 Jan;25(1):98-106. doi: 10.1245/s10434-017-6136-4. Epub 2017 Oct 24.

PMID:
29067605
25.

Cost-Effectiveness of Surveillance for Distant Recurrence in Extremity Soft Tissue Sarcoma.

Royce TJ, Punglia RS, Chen AB, Patel SA, Thornton KA, Raut CP, Baldini EH.

Ann Surg Oncol. 2017 Oct;24(11):3264-3270. doi: 10.1245/s10434-017-5996-y. Epub 2017 Jul 17.

PMID:
28718037
26.

Localized Adult Ewing Sarcoma: Favorable Outcomes with Alternating Vincristine, Doxorubicin, Cyclophosphamide, and Ifosfamide, Etoposide (VDC/IE)-Based Multimodality Therapy.

Pretz JL, Barysauskas CM, George S, Hornick JL, Raut CP, Chen YE, Marcus KJ, Choy E, Hornicek F, Ready JE, DeLaney TF, Baldini EH.

Oncologist. 2017 Oct;22(10):1265-1270. doi: 10.1634/theoncologist.2016-0463. Epub 2017 May 26.

27.

Soft tissue sarcoma nomograms and their incorporation into practice.

Callegaro D, Miceli R, Mariani L, Raut CP, Gronchi A.

Cancer. 2017 Aug 1;123(15):2802-2820. doi: 10.1002/cncr.30721. Epub 2017 May 10. Review.

28.

Histologic Appearance After Preoperative Radiation Therapy for Soft Tissue Sarcoma: Assessment of the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group Response Score.

Schaefer IM, Hornick JL, Barysauskas CM, Raut CP, Patel SA, Royce TJ, Fletcher CDM, Baldini EH.

Int J Radiat Oncol Biol Phys. 2017 Jun 1;98(2):375-383. doi: 10.1016/j.ijrobp.2017.02.087. Epub 2017 Feb 24.

PMID:
28463157
29.

A Rational Approach to Surgery for Retroperitoneal Sarcomas: Extent of Resection Tailored to Histologic Findings.

Raut CP.

Int J Radiat Oncol Biol Phys. 2017 Jun 1;98(2):273. doi: 10.1016/j.ijrobp.2017.01.231. No abstract available.

PMID:
28463148
30.

Cytoreductive Surgery for Metastatic Gastrointestinal Stromal Tumors Treated With Tyrosine Kinase Inhibitors: A 2-institutional Analysis.

Fairweather M, Balachandran VP, Li GZ, Bertagnolli MM, Antonescu C, Tap W, Singer S, DeMatteo RP, Raut CP.

Ann Surg. 2018 Aug;268(2):296-302. doi: 10.1097/SLA.0000000000002281.

31.

Postoperative Morbidity After Radical Resection of Primary Retroperitoneal Sarcoma: A Report From the Transatlantic RPS Working Group.

MacNeill AJ, Gronchi A, Miceli R, Bonvalot S, Swallow CJ, Hohenberger P, Van Coevorden F, Rutkowski P, Callegaro D, Hayes AJ, Honoré C, Fairweather M, Cannell A, Jakob J, Haas RL, Szacht M, Fiore M, Casali PG, Pollock RE, Barretta F, Raut CP, Strauss DC.

Ann Surg. 2018 May;267(5):959-964. doi: 10.1097/SLA.0000000000002250.

PMID:
28394870
32.

Management of Gastrointestinal Stromal Tumors.

Keung EZ, Raut CP.

Surg Clin North Am. 2017 Apr;97(2):437-452. doi: 10.1016/j.suc.2016.12.001. Review.

PMID:
28325196
33.

MAX inactivation is an early event in GIST development that regulates p16 and cell proliferation.

Schaefer IM, Wang Y, Liang CW, Bahri N, Quattrone A, Doyle L, Mariño-Enríquez A, Lauria A, Zhu M, Debiec-Rychter M, Grunewald S, Hechtman JF, Dufresne A, Antonescu CR, Beadling C, Sicinska ET, van de Rijn M, Demetri GD, Ladanyi M, Corless CL, Heinrich MC, Raut CP, Bauer S, Fletcher JA.

Nat Commun. 2017 Mar 8;8:14674. doi: 10.1038/ncomms14674.

34.

Cutaneous Radiation-associated Breast Angiosarcoma: Radicality of Surgery Impacts Survival.

Li GZ, Fairweather M, Wang J, Orgill DP, Bertagnolli MM, Raut CP.

Ann Surg. 2017 Apr;265(4):814-820. doi: 10.1097/SLA.0000000000001753.

PMID:
28267696
35.

Loss of PTEN Is Associated with Resistance to Anti-PD-1 Checkpoint Blockade Therapy in Metastatic Uterine Leiomyosarcoma.

George S, Miao D, Demetri GD, Adeegbe D, Rodig SJ, Shukla S, Lipschitz M, Amin-Mansour A, Raut CP, Carter SL, Hammerman P, Freeman GJ, Wu CJ, Ott PA, Wong KK, Van Allen EM.

Immunity. 2017 Feb 21;46(2):197-204. doi: 10.1016/j.immuni.2017.02.001.

36.

Post-relapse outcomes after primary extended resection of retroperitoneal sarcoma: A report from the Trans-Atlantic RPS Working Group.

MacNeill AJ, Miceli R, Strauss DC, Bonvalot S, Hohenberger P, Van Coevorden F, Rutkowski P, Callegaro D, Hayes AJ, Honoré C, Fairweather M, Cannell A, Jakob J, Haas RL, Szacht M, Fiore M, Casali PG, Pollock RE, Raut CP, Gronchi A, Swallow CJ.

Cancer. 2017 Jun 1;123(11):1971-1978. doi: 10.1002/cncr.30572. Epub 2017 Feb 2.

37.

Incidence and Adverse Prognostic Implications of Histopathologic Organ Invasion in Primary Retroperitoneal Sarcoma.

Fairweather M, Wang J, Jo VY, Baldini EH, Bertagnolli MM, Raut CP.

J Am Coll Surg. 2017 May;224(5):876-883. doi: 10.1016/j.jamcollsurg.2017.01.044. Epub 2017 Jan 29.

PMID:
28147251
38.

Surveillance Imaging Patterns and Outcomes Following Radiation Therapy and Radical Resection for Localized Extremity and Trunk Soft Tissue Sarcoma.

Patel SA, Royce TJ, Barysauskas CM, Thornton KA, Raut CP, Baldini EH.

Ann Surg Oncol. 2017 Jun;24(6):1588-1595. doi: 10.1245/s10434-016-5755-5. Epub 2017 Jan 5.

PMID:
28058559
39.

Are We Allowed to Limit Surgical Aggressiveness With Small Rectal Gastrointestinal Stromal Tumors?

Fiore M, Raut CP, Gronchi A.

Ann Surg Oncol. 2017 May;24(5):1153-1156. doi: 10.1245/s10434-016-5710-5. Epub 2016 Nov 29. No abstract available.

PMID:
27900631
40.
41.

Preface.

Raut CP.

Surg Oncol Clin N Am. 2016 Oct;25(4):xv-xvii. doi: 10.1016/j.soc.2016.07.011. Epub 2016 Aug 5. No abstract available.

PMID:
27591505
42.

Surgical Management of Metastatic Disease.

Keung EZ, Fairweather M, Raut CP.

Surg Clin North Am. 2016 Oct;96(5):1175-92. doi: 10.1016/j.suc.2016.05.010. Review.

PMID:
27542649
43.

Diagnostic and treatment strategy for small gastrointestinal stromal tumors.

Nishida T, Goto O, Raut CP, Yahagi N.

Cancer. 2016 Oct 15;122(20):3110-3118. doi: 10.1002/cncr.30239. Epub 2016 Aug 1. Review.

44.

Acute gastrointestinal toxicity and bowel bag dose-volume parameters for preoperative radiation therapy for retroperitoneal sarcoma.

Mak KS, Phillips JG, Barysauskas CM, Lee LK, Mannarino EG, Van Benthuysen L, Raut CP, Mullen JT, Fairweather M, DeLaney TF, Baldini EH.

Pract Radiat Oncol. 2016 Sep-Oct;6(5):360-366. doi: 10.1016/j.prro.2015.12.005. Epub 2015 Dec 19.

PMID:
27009922
45.

External validation of a multi-institutional retroperitoneal sarcoma nomogram.

Raut CP, Miceli R, Strauss DC, Swallow CJ, Hohenberger P, van Coevorden F, Rutkowski P, Fiore M, Callegaro D, Casali PG, Haas RL, Hayes AJ, Honore C, Cannell AJ, Jakob J, Szacht M, Fairweather M, Pollock RE, Bonvalot S, Gronchi A.

Cancer. 2016 May 1;122(9):1417-24. doi: 10.1002/cncr.29931. Epub 2016 Feb 24.

46.

The Role of Surgery in Metastatic Gastrointestinal Stromal Tumors.

Keung EZ, Fairweather M, Raut CP.

Curr Treat Options Oncol. 2016 Feb;17(2):8. doi: 10.1007/s11864-015-0384-y. Review.

PMID:
26820287
47.

Neoadjuvant Therapy for Soft-Tissue Sarcomas.

Fairweather M, Keung E, Raut CP.

Oncology (Williston Park). 2016 Jan;30(1):99-106. Review.

48.

Variability in Patterns of Recurrence After Resection of Primary Retroperitoneal Sarcoma (RPS): A Report on 1007 Patients From the Multi-institutional Collaborative RPS Working Group.

Gronchi A, Strauss DC, Miceli R, Bonvalot S, Swallow CJ, Hohenberger P, Van Coevorden F, Rutkowski P, Callegaro D, Hayes AJ, Honoré C, Fairweather M, Cannell A, Jakob J, Haas RL, Szacht M, Fiore M, Casali PG, Pollock RE, Raut CP.

Ann Surg. 2016 May;263(5):1002-9. doi: 10.1097/SLA.0000000000001447.

PMID:
26727100
49.

Musical preference correlates closely to professional roles and specialties in operating room: A multicenter cross-sectional cohort study with 672 participants.

Yamasaki A, Mise Y, Mise Y, Lee JE, Aloia TA, Katz MH, Chang GJ, Lillemoe KD, Raut CP, Conrad C.

Surgery. 2016 May;159(5):1260-8. doi: 10.1016/j.surg.2015.10.031. Epub 2015 Dec 23.

PMID:
26706609
50.

Retroperitoneal sarcoma (RPS) high risk gross tumor volume boost (HR GTV boost) contour delineation agreement among NRG sarcoma radiation and surgical oncologists.

Baldini EH, Bosch W, Kane JM 3rd, Abrams RA, Salerno KE, Deville C, Raut CP, Petersen IA, Chen YL, Mullen JT, Millikan KW, Karakousis G, Kendrick ML, DeLaney TF, Wang D.

Ann Surg Oncol. 2015 Sep;22(9):2846-52. doi: 10.1245/s10434-015-4633-x. Epub 2015 May 28.

Supplemental Content

Support Center